<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03615781</url>
  </required_header>
  <id_info>
    <org_study_id>no. 15-014</org_study_id>
    <nct_id>NCT03615781</nct_id>
  </id_info>
  <brief_title>Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis</brief_title>
  <official_title>Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal duration of systemic antibiotic administration for native joint septic arthritis
      is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages
      and allocating patients into a two-week's and a four week's randomization arm
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The optimal duration of systemic antibiotic administration for native joint septic arthritis
      is unknown. The investigators perform a randomized study allocating patients into a
      two-week's and a four week's randomization arm.

      The adult patients are hospitalized for septic arthritis. A computer program randomizes 1:1
      between a two week's and a four week's arm of targeted antibiotic treatment of which at least
      the first week is intravenously. The randomization may occur until Day 5 of admission. Up to
      three surgical interventions are allowed. The investigators allow the inclusion of all
      bacterial arthritis and all joints.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">May 18, 2018</completion_date>
  <primary_completion_date type="Actual">April 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Remission of systemic infection</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of fever.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sequels</measure>
    <time_frame>6 months</time_frame>
    <description>Patient's remaining gait disorders.
range of movement in adjacent joints of former infection
questionnaire regarding persistant pain and handicaps (open wording)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound redness</measure>
    <time_frame>6 months</time_frame>
    <description>Visual examination of the presence of wound redness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound discharge</measure>
    <time_frame>6 months</time_frame>
    <description>Visual examination of the presence of wound discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of pus</measure>
    <time_frame>6 months</time_frame>
    <description>Visual examination of the presence of pus coming out the wound</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Arthritis, Septic</condition>
  <arm_group>
    <arm_group_label>Two week's arm - surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators perform a surgical drainage and removal of the infected orthopedic implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Four week's arm - surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators surgically remove the infected implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two week's arm - drugs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators perform a surgical drainage and removal of the infected orthopedic implant. They start an empirical antibiotic treatment based on patient's history and co-morbidities, such as vancomycin or amoxicillin/clavulanic acid. The adapt later on the targeted antibiotic therapy according to the causative pathogens and their antibiotic susceptibility testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Four week's arm - drugs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators surgically remove the infected implant and all soft tissue infection. Instead of a total of 2 week's of antibiotic therapy, they administer a total of 4 weeks of systemic antibiotic therapy targeted to the pathogen(s).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Two week's arm - surgery</intervention_name>
    <description>The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.</description>
    <arm_group_label>Two week's arm - surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Four week's arm - surgery</intervention_name>
    <description>The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.</description>
    <arm_group_label>Four week's arm - surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Two week's arm - drugs</intervention_name>
    <description>After the surgical implant removal, the investigators prescribe a total of 2 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.</description>
    <arm_group_label>Two week's arm - drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Four week's arm - drugs</intervention_name>
    <description>After the surgical implant removal, the investigators prescribe a total of 4 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.</description>
    <arm_group_label>Four week's arm - drugs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;17 years

          2. Microbiologically-confirmed septic arthritis

          3. At least one surgical drainage/lavage

        Exclusion Criteria:

          1. Presence of osteosynthesis material in the vicinity of the articulation

          2. Presence of a concomitant infection needing more than 2 week's of antibiotic therapy

          3. More than 3 surgical drainages

          4. Life expectancy less than 6 months

          5. Chronic osteomyelitis in vicinity of the arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilker Uçkay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Uçkay I, Tovmirzaeva L, Garbino J, Rohner P, Tahintzi P, Suvà D, Assal M, Hoffmeyer P, Bernard L, Lew D. Short parenteral antibiotic treatment for adult septic arthritis after successful drainage. Int J Infect Dis. 2013 Mar;17(3):e199-205. doi: 10.1016/j.ijid.2011.12.019. Epub 2012 Nov 22.</citation>
    <PMID>23183231</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>January 16, 2017</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>July 30, 2018</last_update_submitted>
  <last_update_submitted_qc>July 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Ilker Uckay</investigator_full_name>
    <investigator_title>Attending, Docent Dr. med Ilker Uçkay</investigator_title>
  </responsible_party>
  <keyword>septic arthritis</keyword>
  <keyword>surgery</keyword>
  <keyword>antibiotic duration</keyword>
  <keyword>remission</keyword>
  <keyword>sequelae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Infectious</mesh_term>
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

